News and Trends 15 May 2023
New menopause drug gets FDA approval
The U.S. Food and Drug Administration has approved Astellas Pharma's Veozah (fezolinetant), an oral medication for the treatment of moderate…
menopause
- Latest Posts
News and Trends 14 Mar 2023
Astellas menopause study meets endpoints but leukemia drug disappoints
There was good and bad news this week from Japanese company Astellas Pharma Inc. as one of its trials yielded…
News and Trends 30 Sep 2022
Treatment for hot flushes and night sweats accepted for regulatory review by EMA
A treatment for moderate to severe vasomotor symptoms (VMS) has been accepted by the European Medicines Agency (EMA) for regulatory…
News and Trends 5 Sep 2022
Astellas ‘encouraged’ by menopause symptom treatment results in China
Astellas Pharma Inc. has announced topline results from its phase 3 MOONLIGHT 3 clinical trial in women in mainland China…
ADVERTISEMENT
More News! 24 Jun 2022
Gurnet Point Capital and Patient Square Capital buy Radius Health for $890M
Global pharmaceutical company, Radius Health Inc, announced this week (June 23) that it has entered into a definitive agreement to…
